HART Profile
The IQ Healthy Hearts ETF (HART) tracks the IQ Candriam Healthy Hearts Index, a market-cap-weighted benchmark comprising global stocks recognized for their positive health-related environmental, social, and governance (ESG) ratings. Launched on January 14, 2021, HART offers investors exposure to companies actively contributing to health advancements, encompassing sectors such as pharmaceuticals, biotechnology, healthcare services, and medical technology.
HART's index methodology emphasizes selecting companies with robust ESG practices specifically aligned with promoting heart health and overall well-being. This strategic focus not only aims to generate financial returns but also supports sustainable investment principles by prioritizing companies committed to improving global health outcomes through innovative products and services.
IndexIQ, the issuer of HART, specializes in developing ETFs that target thematic investment strategies, including those centered on health and wellness themes. HART exemplifies IndexIQ's dedication to offering investment solutions that integrate ESG considerations, providing investors with opportunities to align their portfolios with societal and environmental priorities.
Investing in HART allows market participants to support companies leading in health-related ESG initiatives while potentially benefiting from opportunities in the rapidly evolving healthcare sector. IndexIQ's management of HART underscores its commitment to transparency and responsible investing, positioning the ETF as a strategic choice for investors seeking exposure to companies at the forefront of promoting healthy hearts globally.
|
